Profile data is unavailable for this security.
About the company
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
- Revenue in USD (TTM)11.66m
- Net income in USD-49.15m
- Incorporated2003
- Employees79.00
- LocationBioLine RX LtdModi'in Technology Park2 HaMa'ayan StreetMODIIN 7177871IsraelISR
- Phone+972 86429100
- Fax+972 86429101
- Websitehttps://www.biolinerx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc | 15.07m | -81.22m | 52.34m | 107.00 | -- | 4.80 | -- | 3.47 | -2.01 | -2.01 | 0.3723 | 0.2623 | 0.1311 | -- | -- | 140,869.20 | -70.64 | -30.87 | -83.17 | -34.47 | -- | -- | -538.81 | -255.66 | -- | -- | 0.1717 | -- | -62.70 | -- | -336.93 | -- | 255.27 | -- |
| Estrella Immunopharma Inc | 0.00 | -2.16m | 54.56m | -- | -- | 5.24 | -- | -- | -1.90 | -1.90 | 0.00 | 0.2861 | 0.00 | -- | -- | -- | -5.92 | -- | -7.86 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -302.11 | -- | -- | -- |
| Atara Biotherapeutics Inc | 34.70m | -233.11m | 54.73m | 173.00 | -- | -- | -- | 1.58 | -52.93 | -52.93 | 7.54 | -20.43 | 0.1485 | 0.9947 | 1.92 | 154,240.00 | -99.76 | -70.20 | -213.09 | -86.94 | 69.30 | -- | -671.70 | -1,559.33 | 0.50 | -- | -- | -- | -86.51 | -- | -20.95 | -- | -49.14 | -- |
| VolitionRX Ltd | 797.03k | -34.91m | 54.73m | 110.00 | -- | -- | -- | 68.67 | -0.4603 | -0.4603 | 0.0104 | -0.1901 | 0.0425 | -- | 6.32 | 7,245.73 | -188.25 | -111.92 | -- | -196.20 | -- | -- | -4,425.95 | -10,793.31 | -- | -173.85 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Aerovate Therapeutics Inc | 0.00 | -82.19m | 54.74m | 51.00 | -- | 0.5831 | -- | -- | -3.03 | -3.03 | 0.00 | 3.26 | 0.00 | -- | -- | 0.00 | -71.09 | -- | -80.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -46.61 | -- | -- | -- |
| Inotiv Inc | 552.74m | -71.29m | 55.06m | 1.96k | -- | 0.2651 | -- | 0.0996 | -2.77 | -2.77 | 21.44 | 8.00 | 0.6565 | 7.18 | 7.91 | 282,733.50 | -8.58 | -23.84 | -13.63 | -29.26 | 28.76 | 29.31 | -13.07 | -33.24 | 0.2744 | -0.0193 | 0.6476 | -- | 4.52 | 85.10 | 68.80 | -- | 83.64 | -- |
| Rallybio Corp | 0.00 | -76.28m | 55.54m | 43.00 | -- | 0.5683 | -- | -- | -1.88 | -1.88 | 0.00 | 2.36 | 0.00 | -- | -- | 0.00 | -58.30 | -- | -62.32 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.87 | -- | -- | -- |
| Mural Oncology PLC | 0.00 | -191.90m | 56.02m | 117.00 | -- | 0.2384 | -- | -- | -11.49 | -11.49 | 0.00 | 13.88 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
| Passage Bio Inc | 0.00 | -84.44m | 56.79m | 58.00 | -- | 0.5412 | -- | -- | -1.53 | -1.53 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -47.73 | -48.56 | -52.17 | -52.09 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.02 | -- | -43.53 | -- |
| Cidara Therapeutics Inc | 46.38m | -36.47m | 57.02m | 69.00 | -- | -- | -- | 1.23 | -8.07 | -8.07 | 10.26 | -3.90 | 0.6899 | -- | 2.80 | 672,144.90 | -54.24 | -65.23 | -218.59 | -154.37 | 76.93 | -- | -78.63 | -100.61 | 0.6047 | -- | -- | -- | -0.8425 | -- | 31.72 | -- | 23.33 | -- |
| BioLine RX Ltd - ADR | 11.66m | -49.15m | 57.60m | 79.00 | -- | 4.22 | -- | 4.94 | -0.7628 | -0.7628 | 0.1741 | 0.1803 | 0.1939 | -- | 6.40 | 147,531.60 | -81.75 | -52.74 | -127.94 | -65.43 | 55.84 | -- | -421.69 | -3,501.79 | 1.05 | -519.43 | 0.4642 | -- | -- | -- | -142.93 | -- | -50.72 | -- |
| Enzo Biochem Inc | 33.34m | -17.55m | 60.21m | 179.00 | -- | 0.8683 | -- | 1.81 | -0.3516 | 0.9194 | 0.6633 | 1.35 | 0.4028 | 1.66 | 4.91 | 186,257.00 | -21.20 | -12.21 | -34.50 | -15.79 | 43.66 | 37.09 | -52.63 | -18.76 | 3.16 | -- | 0.053 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
| RetinalGenix Technologies Inc | 0.00 | -3.73m | 62.51m | 0.00 | -- | -- | -- | -- | -0.2124 | -0.2124 | 0.00 | -0.085 | 0.00 | -- | -- | -- | -12,800.17 | -9,163.75 | -- | -- | -- | -- | -- | -- | -- | -969.35 | -- | -- | -- | -- | 46.58 | -- | -- | -- |
| Anebulo Pharmaceuticals Inc | 0.00 | -9.35m | 62.76m | 2.00 | -- | 12.59 | -- | -- | -0.3633 | -0.3633 | 0.00 | 0.1922 | 0.00 | -- | -- | 0.00 | -91.51 | -- | -104.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.89 | -- | -- | -- |
Data as of Jul 16 2024. Currency figures normalised to BioLine RX Ltd's reporting currency: US Dollar USD
1.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Susquehanna Financial Group LLLPas of 31 Mar 2024 | 204.91k | 0.26% |
| Values First Advisors, Inc.as of 31 Mar 2024 | 203.63k | 0.26% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 187.49k | 0.24% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 103.87k | 0.13% |
| LPL Financial LLCas of 31 Mar 2024 | 100.32k | 0.13% |
| Western International Securities, Inc.as of 31 Mar 2024 | 99.33k | 0.12% |
| PVG Asset Management Corp.as of 31 Dec 2023 | 61.84k | 0.08% |
| Envestnet Asset Management, Inc.as of 31 Mar 2024 | 54.41k | 0.07% |
| Geode Capital Management LLCas of 31 Mar 2024 | 39.99k | 0.05% |
| Rathbones Investment Management Ltd.as of 31 Mar 2024 | 39.82k | 0.05% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
